Published 3 years ago

Spacing Pfizer COVID shots boosts antibody levels after initial drop

Summary by Ground News

UK study: Giving the second dose eight weeks after the first is the "sweet spot" to protect against the fast-spreading Delta variant. Waiting longer to get a second dose presents a trade-off because people are less protected after just one shot. Two doses of Pfizer's shot boosted immune responses higher than one dose, study authors said.

0 Articles

All

Left

Center

Right

BBC News

Eight-week gap seen as sweet spot for Pfizer jab antibodies

Spacing out the two doses beyond a month boosts antibody levels, researchers find.

3 years ago·United Kingdom

Read Full Article

Yahoo News

Spacing Pfizer COVID shots boosts antibody levels after initial drop

A longer gap between doses of Pfizer's COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but there is a sharp drop in antibody levels after the first dose. "For the longer dosing interval ... neutralising antibody levels against the Delta variant were poorly induced after a single dose, and not maintained during the interval before the second dose," the authors of the study, which is b…

3 years ago·Los Angeles, United States

Read Full Article

The Guardian

Pfizer vaccine second dose has ‘sweet spot’ after eight weeks, UK scientists say

Longer schedule led to more Covid antibodies and higher proportion of helper T-cells, supporting immune memory – researchers

3 years ago·London, United Kingdom

Read Full Article

The Independent

Eight-week dose interval a ‘sweet spot’ for Pfizer vaccine, says scientists

A new study has shown that a longer dosing interval with the Pfizer jab generates more neutralising antibodies and ‘helper’ T cells against the Covid virus

3 years ago·London, United Kingdom

Read Full Article

Reuters

Spacing Pfizer COVID shots boosts antibody levels after initial drop

LONDON - A longer gap between doses of Pfizer's COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but there is a sharp drop in antibody levels after the first dose. The study might help inform vaccination strategies against the Delta variant, which reduces the effectiveness of a first dose of COVID-19 vaccine even though two

3 years ago·United Kingdom

Read Full Article

NDTV

Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds

An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.

3 years ago·New Delhi, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.